Current and historical daily PE Ratio for Harbin Medisan Pharmaceutical Co Ltd (
) from 2017 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Harbin Medisan Pharmaceutical stock (SZSE:002900) PE ratio as of Jun 10 2024 is 56.06.
More Details
Harbin Medisan Pharmaceutical Co Ltd (SZSE:002900) PE Ratio (TTM) Chart
Harbin Medisan Pharmaceutical Co Ltd (SZSE:002900) PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 1201
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Harbin Medisan Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-11 | 56.1 | 2024-04-01 | 60.4 |
| 2024-06-07 | 53.8 | 2024-03-29 | 59.3 |
| 2024-06-06 | 52.1 | 2024-03-28 | 58.4 |
| 2024-06-05 | 55.5 | 2024-03-27 | 41.2 |
| 2024-06-04 | 59.0 | 2024-03-26 | 41.5 |
| 2024-06-03 | 58.6 | 2024-03-25 | 41.4 |
| 2024-05-31 | 61.6 | 2024-03-22 | 42.5 |
| 2024-05-30 | 61.0 | 2024-03-21 | 43.2 |
| 2024-05-29 | 64.9 | 2024-03-20 | 43.5 |
| 2024-05-28 | 63.2 | 2024-03-19 | 43.0 |
| 2024-05-27 | 65.0 | 2024-03-18 | 42.4 |
| 2024-05-24 | 67.2 | 2024-03-15 | 41.5 |
| 2024-05-23 | 71.2 | 2024-03-14 | 41.8 |
| 2024-05-22 | 64.8 | 2024-03-13 | 41.1 |
| 2024-05-21 | 58.9 | 2024-03-12 | 41.3 |
| 2024-05-20 | 60.1 | 2024-03-11 | 39.6 |
| 2024-05-17 | 59.5 | 2024-03-08 | 38.9 |
| 2024-05-16 | 59.1 | 2024-03-07 | 38.7 |
| 2024-05-15 | 59.1 | 2024-03-06 | 39.3 |
| 2024-05-14 | 59.6 | 2024-03-05 | 39.5 |
| 2024-05-13 | 58.6 | 2024-03-04 | 40.6 |
| 2024-05-10 | 60.5 | 2024-03-01 | 39.5 |
| 2024-05-09 | 61.9 | 2024-02-29 | 39.3 |
| 2024-05-08 | 61.1 | 2024-02-28 | 38.1 |
| 2024-05-07 | 62.1 | 2024-02-27 | 42.0 |
| 2024-05-06 | 61.3 | 2024-02-26 | 41.0 |
| 2024-04-30 | 58.4 | 2024-02-23 | 39.5 |
| 2024-04-29 | 58.8 | 2024-02-22 | 38.1 |
| 2024-04-26 | 58.1 | 2024-02-21 | 36.9 |
| 2024-04-25 | 59.0 | 2024-02-20 | 36.2 |
| 2024-04-24 | 57.6 | 2024-02-19 | 35.5 |
| 2024-04-23 | 58.2 | 2024-02-08 | 33.8 |
| 2024-04-22 | 58.6 | 2024-02-07 | 30.7 |
| 2024-04-19 | 65.1 | 2024-02-06 | 34.1 |
| 2024-04-18 | 72.3 | 2024-02-05 | 35.5 |
| 2024-04-17 | 77.0 | 2024-02-02 | 39.5 |
| 2024-04-16 | 70.0 | 2024-02-01 | 42.5 |
| 2024-04-15 | 63.6 | 2024-01-31 | 43.3 |
| 2024-04-12 | 57.9 | 2024-01-30 | 46.2 |
| 2024-04-11 | 59.6 | 2024-01-29 | 47.9 |
| 2024-04-10 | 58.2 | 2024-01-26 | 49.5 |
| 2024-04-09 | 60.4 | 2024-01-25 | 49.5 |
| 2024-04-08 | 58.2 | 2024-01-24 | 47.3 |
| 2024-04-03 | 60.6 | 2024-01-23 | 46.8 |
| 2024-04-02 | 60.6 | 2024-01-22 | 47.4 |
Harbin Medisan Pharmaceutical Co Ltd (SZSE:002900) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Harbin Medisan Pharmaceutical Co Ltd
ISIN : CNE1000032V9
Share Class Description:
SZSE:002900: Class ACompare
Compare
Traded in other countries / regions
002900.China IPO Date
2017-09-22Description
Harbin Medisan Pharmaceutical Co Ltd is the pharmaceutical manufacturing company. It is engaged in the research, development, manufacturing and sales of chemical preparations. The main products are oxiracetam injection, mirtazapine tablets, valsartan dispersible tablets, injection brain drugs such as protein hydrolysate, glucose injection and sodium chloride injection. The company is also involved in research, development, production and sales of medical devices.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers